24.6 C
Delhi
Wednesday, April 2, 2025

DCGI approves Themis Medicare’s VIRALEX® for Covid-19 treatment

Must read

Reading Time: < 1 minute

Enhances both innate & adaptive immunity and strengthens body’s immune response to viral infections March 5: In a landmark development for the treatment of COVID-19, Themis Medicare Ltd. (Themis), a Pharmaceutical company headquartered in Mumbai with a legacy of over 50 years of making new treatment options available, announced the approval of its antiviral drug […]

The post DCGI approves Themis Medicare’s VIRALEX® for Covid-19 treatment appeared first on Startup Reporter.

Source: Women Entrepreneur

The post DCGI approves Themis Medicare’s VIRALEX® for Covid-19 treatment appeared first on The Pink Journey.

Views: 0

- Advertisement -spot_img

More articles

- Advertisement -spot_img

Latest article